Literature DB >> 18417085

Adenocarcinoma of the gastroesophageal junction after bariatric surgery.

Laleh G Melstrom1, David J Bentrem, Michael J Salvino, Matthew G Blum, Mark S Talamonti, Kenneth J Printen.   

Abstract

BACKGROUND: The development of upper gastrointestinal malignancies after bariatric surgery has not been well characterized. Our objective was to review the experience of patients with distal esophageal cancer that was diagnosed after bariatric surgery.
METHODS: A retrospective review was conducted to identify patients who had undergone bariatric surgery (1999 to 2006) and who later developed high-grade dysplasia or adenocarcinoma of the distal esophagus.
RESULTS: Three patients (of 2,875 [0.1%]) developed esophageal cancer: 2 after Roux-en-Y gastric bypass and 1 after vertical banded gastroplasty. All three patients had complaints of reflux, and two were treated with esophagectomy. The third patient presented with invasive carcinoma and died 2 years after diagnosis.
CONCLUSIONS: Our findings emphasize the importance of precise endoscopic evaluation before bariatric surgery in patients with gastroesophageal reflux disease (GERD), of the necessity for continuing postsurgical surveillance in patients with known Barrett's esophagitis, and of early evaluation in patients who develop new symptoms of GERD after bariatric surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18417085     DOI: 10.1016/j.amjsurg.2007.07.026

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Laparoscopic Adjustable Gastric Banding: an Underestimated Risk Factor for the Development of Esophageal Cancer?-a Nationwide Survey.

Authors:  Philipp Gehwolf; Katrin Kienzl-Wagner; Fergül Cakar-Beck; Aline Schäfer; Heinz Wykypiel
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

Review 2.  Gastro-Intestinal Tract Cancers Following Bariatric Surgery: a Narrative Review.

Authors:  Reza Ebrahimi; Mohammad Kermansaravi; Alireza Khalaj; Foolad Eghbali; Ali Mousavi; Abdolreza Pazouki
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

3.  Mechano-transcription of COX-2 is a common response to lumen dilation of the rat gastrointestinal tract.

Authors:  Y-M Lin; F Li; X-Z Shi
Journal:  Neurogastroenterol Motil       Date:  2012-04-10       Impact factor: 3.598

Review 4.  Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis.

Authors:  Rodrigue Chemaly; Samer Diab; Georges Khazen; Georges Al-Hajj
Journal:  Obes Surg       Date:  2022-01-27       Impact factor: 4.129

5.  Oesophageal and Gastric Cancer After Bariatric Surgery: an Up-to-Date Systematic Scoping Review of Literature of 324 Cases.

Authors:  Chetan Parmar; Sjaak Pouwels
Journal:  Obes Surg       Date:  2022-10-15       Impact factor: 3.479

Review 6.  Gastroesophageal reflux disease and morbid obesity: is there a relation?

Authors:  Piero M Fisichella; Marco G Patti
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

Review 7.  Benign, premalignant, and malignant lesions encountered in bariatric surgery.

Authors:  Rao S Raghavendra; Dr Kini
Journal:  JSLS       Date:  2012 Jul-Sep       Impact factor: 2.172

8.  Effect of bariatric surgery on future general surgical procedures.

Authors:  Subhash Kini; Umashankkar Kannan
Journal:  J Minim Access Surg       Date:  2011-04       Impact factor: 1.407

9.  Laparoscopic transhiatal esophagectomy for esophageal adenocarcinoma identified at laparoscopic Roux-en-Y gastric bypass.

Authors:  Halle B Ellison; David M Parker; Ryan D Horsley; Daaron McField; Michael E Friscia; Anthony T Petrick
Journal:  Int J Surg Case Rep       Date:  2016-06-11

10.  Esophageal Pathophysiologic Changes and Adenocarcinoma After Bariatric Surgery: A Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Reem Matar; Karthik Ravi; M Hassan Murad; Kornpong Vantanasiri; Nicha Wongjarupong; Patompong Ungprasert; Eric J Vargas; Daniel B Maselli; Larry J Prokop; Barham K Abu Dayyeh
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.